Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Misonix, Inc.
  6. News
  7. Summary
    MSON   US6048711039

MISONIX, INC.

(MSON)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Misonix : Q4 Net Loss Narrows, Revenue Surges

09/02/2021 | 04:13pm EST


ę MT Newswires 2021
All news about MISONIX, INC.
10/31MISONIX, INC.(NASDAQGM : MSON) dropped from S&P TMI Index
CI
10/31MISONIX, INC.(NASDAQGM : MSON) dropped from S&P Global BMI Index
CI
10/29MISONIX INC : Termination of a Material Definitive Agreement, Completion of Acquisition or..
AQ
10/29MISONIX, INC.(NASDAQGM : MON) dropped from NASDAQ Composite Index
CI
10/29Bioventus Inc. completed the acquisition of Misonix, Inc. from Stavros G. Vizirgianakis..
CI
10/26MISONIX INC : Submission of Matters to a Vote of Security Holders, Regulation FD Disclosur..
AQ
10/18MISONIX INC : Other Events (form 8-K)
AQ
09/02MISONIX : Management's Discussion and Analysis of Financial Condition and Results of Opera..
AQ
09/02MISONIX : Q4 Net Loss Narrows, Revenue Surges
MT
09/02MISONIX : REPORTS FOURTH QUARTER AND FISCAL YEAR 2021 FINANCIAL RESULTS (Form 8-K)
PU
More news
Analyst Recommendations on MISONIX, INC.
More recommendations
Financials (USD)
Sales 2021 74,0 M - -
Net income 2021 -14,5 M - -
Net Debt 2021 16,2 M - -
P/E ratio 2021 -26,4x
Yield 2021 -
Capitalization 463 M 463 M -
EV / Sales 2020 3,88x
EV / Sales 2021 5,43x
Nbr of Employees 281
Free-Float 79,1%
Chart MISONIX, INC.
Duration : Period :
Misonix, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Daniel Voic VP-Engineering, Research & Development
John Joseph Salerno Chief Compliance Officer & VP-Regulatory Affairs
Sector and Competitors
1st jan.Capi. (M$)
MISONIX, INC.112.32%463
MASIMO CORPORATION5.88%15 691
GETINGE AB100.52%11 520
NOVOCURE LIMITED-43.94%10 072
PENUMBRA, INC.42.95%9 346
SHOCKWAVE MEDICAL, INC.77.02%6 482